These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 26112162)

  • 1. Fecal Calprotectin and serum chromogranin A as potential biomarkers of irritable bowel syndrome symptom severity.
    Pletikosic S; Plavsic I; Hauser G; Tkalcic M
    Med Hypotheses; 2015 Sep; 85(3):339-42. PubMed ID: 26112162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered levels of fecal chromogranins and secretogranins in IBS: relevance for pathophysiology and symptoms?
    Ohman L; Stridsberg M; Isaksson S; Jerlstad P; Simrén M
    Am J Gastroenterol; 2012 Mar; 107(3):440-7. PubMed ID: 22233694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative Effects on Psychological Health and Quality of Life of Genuine Irritable Bowel Syndrome-type Symptoms in Patients With Inflammatory Bowel Disease.
    Gracie DJ; Williams CJ; Sood R; Mumtaz S; Bholah MH; Hamlin PJ; Ford AC
    Clin Gastroenterol Hepatol; 2017 Mar; 15(3):376-384.e5. PubMed ID: 27189912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromogranin A as a possible tool in the diagnosis of irritable bowel syndrome.
    El-Salhy M; Lomholt-Beck B; Hausken T
    Scand J Gastroenterol; 2010 Dec; 45(12):1435-9. PubMed ID: 20602602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moderate to severe and prolonged left lower-abdominal pain is the best symptom characterizing symptomatic uncomplicated diverticular disease of the colon: a comparison with fecal calprotectin in clinical setting.
    Tursi A; Elisei W; Picchio M; Giorgetti GM; Brandimarte G
    J Clin Gastroenterol; 2015 Mar; 49(3):218-21. PubMed ID: 24583746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coexisting irritable bowel-like symptoms in inflammatory bowel disease in remission is associated with impaired social functioning and increased bodily pain.
    Jelsness-Jørgensen LP; Bernklev T; Moum B
    Gastroenterol Nurs; 2014; 37(4):280-7. PubMed ID: 25078042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fecal calprotectin is an effective diagnostic tool that differentiates inflammatory from functional intestinal disorders.
    Caviglia GP; Pantaleoni S; Touscoz GA; Adriani A; Rosso C; Smedile A; Pellicano R; Astegiano M; Bresso F
    Scand J Gastroenterol; 2014 Dec; 49(12):1419-24. PubMed ID: 25369978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of serum chromogranin A in diarrhoea predominant irritable bowel syndrome.
    Sidhu R; McAlindon ME; Leeds JS; Skilling J; Sanders DS
    J Gastrointestin Liver Dis; 2009 Mar; 18(1):23-6. PubMed ID: 19337629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fecal calprotectin in differential diagnosis of irritable bowel syndrome].
    Li XG; Lu YM; Gu F; Yang XL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Jun; 38(3):310-3. PubMed ID: 16778979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated human beta-defensin-2 levels indicate an activation of the innate immune system in patients with irritable bowel syndrome.
    Langhorst J; Junge A; Rueffer A; Wehkamp J; Foell D; Michalsen A; Musial F; Dobos GJ
    Am J Gastroenterol; 2009 Feb; 104(2):404-10. PubMed ID: 19174795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated levels of faecal calprotectin in primary Sjögren's syndrome is common and associated with concomitant organic gastrointestinal disease.
    Andréasson K; Ohlsson B; Mandl T
    Arthritis Res Ther; 2016 Jan; 18():9. PubMed ID: 26759247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced chromogranin A cell density in the ileum of patients with irritable bowel syndrome.
    El-Salhy M; Wendelbo IH; Gundersen D
    Mol Med Rep; 2013 Apr; 7(4):1241-4. PubMed ID: 23426642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of IBS-like symptoms in patients with ulcerative colitis in clinical remission.
    Jonefjäll B; Strid H; Ohman L; Svedlund J; Bergstedt A; Simren M
    Neurogastroenterol Motil; 2013 Sep; 25(9):756-e578. PubMed ID: 23731196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of fecal calprotectin in the diagnosis and treatment of segmental colitis associated with diverticulosis.
    Tursi A; Elisei W; Giorgetti G; Aiello F; Brandimarte G
    Minerva Gastroenterol Dietol; 2011 Sep; 57(3):247-55. PubMed ID: 21769075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Faecal calprotectin in colonic diverticular disease: a case-control study.
    Tursi A; Brandimarte G; Elisei W; Giorgetti GM; Inchingolo CD; Aiello F
    Int J Colorectal Dis; 2009 Jan; 24(1):49-55. PubMed ID: 18941760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroimmune interactions at different intestinal sites are related to abdominal pain symptoms in children with IBS.
    Di Nardo G; Barbara G; Cucchiara S; Cremon C; Shulman RJ; Isoldi S; Zecchi L; Drago L; Oliva S; Saulle R; Barbaro MR; Stronati L
    Neurogastroenterol Motil; 2014 Feb; 26(2):196-204. PubMed ID: 24304324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in Fecal Calprotectin After Rifaximin Treatment in Patients With Nonconstipated Irritable Bowel Syndrome.
    Lee SH; Kim CR; Kim KN
    Am J Med Sci; 2019 Jan; 357(1):23-28. PubMed ID: 30611316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Semiquantitative fecal calprotectin test in postinfectious and non-postinfectious irritable bowel syndrome: cross-sectional study.
    David LE; Surdea-Blaga T; Dumitrascu DL
    Sao Paulo Med J; 2015; 133(4):343-9. PubMed ID: 26039537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromogranin A cell density in the rectum of patients with irritable bowel syndrome.
    El-Salhy M; Mazzawi T; Gundersen D; Hausken T
    Mol Med Rep; 2012 Dec; 6(6):1223-5. PubMed ID: 22992886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal leukocyte proteins in inflammatory bowel disease and irritable bowel syndrome.
    Silberer H; Küppers B; Mickisch O; Baniewicz W; Drescher M; Traber L; Kempf A; Schmidt-Gayk H
    Clin Lab; 2005; 51(3-4):117-26. PubMed ID: 15819166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.